Systemic miRNA-195 Differentiates Breast Cancer from Other Malignancies and Is a Potential Biomarker for Detecting Noninvasive and Early Stage Disease

Overview of attention for article published in Oncologist, June 2010

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (71st percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

patent: 4 patents

Citations

dimensions_citation: 284 Dimensions

Readers on

mendeley: 196 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 4 patents that reference this research output.

METHOD OF DETERMINING THE RISK OF DEVELOPING BREAST CANCER

Application EP-3916106-A1

European Patent Office

Engineered secreted reporters of cellular processes

Grant US-10648042-B1

United States of America

Diagnosing and monitoring CNS malignancies using microRNA

Application US-10100367-B2

United States of America

Diagnosing and monitoring CNS malignancies using MicroRNA

Grant US-9150928-B2

United States of America

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.